Isolated thrombosis due to the cystathionine beta-synthase mutation c.833T>C (1278T)

M Linnebank1, R Junker, D G Nabavi

  • 1Klinik und Poliklinik für Kinderheilkunde, Universitaetsklinikum Münster, Germany. michael.linnebank@ukb.uni-bonn.de

Insights

Hereditary homocystinuria, caused by cystathionine beta-synthase (CBS) deficiency, can lead to isolated thrombosis. The common CBS 1278T mutation was found in patients with stroke and sinus thrombosis, suggesting homocystinuria is underdiagnosed.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Neurology

Background:

  • Hereditary homocystinuria, a rare metabolic disorder due to cystathionine beta-synthase (CBS) deficiency, is often linked to thromboembolism.
  • Specific CBS mutations, particularly those affecting the C-terminal region, can cause isolated thrombosis without other typical homocystinuria symptoms.

Purpose of the Study:

  • To investigate the prevalence of the common CBS 1278T mutation in patients experiencing thrombotic events like stroke and sinus thrombosis.
  • To determine if this mutation, or others, can lead to isolated thrombophilia.

Main Methods:

  • DNA samples from 225 stroke patients and 46 sinus thrombosis patients were screened.
  • The screening specifically targeted the CBS 1278T mutation, a common cause of homocystinuria.

Main Results:

  • One homozygous patient for the CBS 1278T mutation was identified in both the stroke and sinus thrombosis groups.
  • These findings indicate that the CBS 1278T mutation, similar to C-terminal mutations, can result in isolated thrombophilic events.

Conclusions:

  • The presence of the CBS 1278T mutation in patients with isolated thrombosis supports the hypothesis that homocystinuria is an underdiagnosed condition.
  • Screening for CBS mutations should be considered in patients presenting with unexplained thrombotic events.

Related Concept Videos

Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...
Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...